Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]

1995 • 629 citations

Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation

1986 • 528 citations

Prevention of transfusion-acquired cytomegalovirus infections in newborn infants

1981 • 514 citations

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide

1994 • 373 citations

Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus

1994 • 241 citations

Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant

1991 • 209 citations

Claims of Equivalence in Medical Research: Are They Supported by the Evidence?

2000 • 185 citations

Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines.

1997 • 160 citations

Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients

1999 • 158 citations

Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients

1999 • 137 citations

Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.

1991 • 135 citations

Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

1992 • 130 citations

Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial

1997 • 129 citations

PREVENTION OF PRIMARY CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION BY USING LEUKOCYTE-POOR RANDOM BLOOD PRODUCTS FROM CYTOMEGALOVIRUS-UNSCREENED BLOOD-BANK DONORS

1990 • 109 citations

Proceedings of a Consensus Conference: Prevention of Post-Transfusion CMV in the Era of Universal Leukoreduction1

2001 • 97 citations

Cytomegalovirus pp65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell Transplantation

1996 • 84 citations

CMV and blood transfusions

2002 • 84 citations

Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.

1987 • 78 citations

Prevention of primary transfusion‐associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high‐affinity filters

1994 • 74 citations

Current concepts in transfusion therapy

1985 • 65 citations

Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors

2002 • 63 citations

The cytomegalovirus-“safe” blood product: Is leukoreduction equivalent to antibody screening?

2000 • 62 citations

The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods

2001 • 55 citations

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

1994 • 46 citations

The preparation of leukocyte‐poor red blood cells: a comparative study

1980 • 45 citations

Universal Leukoreduction of Cellular Blood Components in 2001?

2001 • 38 citations

Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection [letter; comment]

1996 • 36 citations

Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients

1998 • 32 citations

Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.

1995 • 27 citations

Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence

1996 • 27 citations

Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.

1991 • 26 citations

Universal Leukoreduction of Cellular Blood Components in 2001?

2001 • 18 citations

High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMV

2001 • 5 citations